Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - CASH FROM OPERATIONS
Cash from Operations ADAP - Adaptimmune Therapeutics plc
-73.2 M
LAST VALUE
28.14%
2 YEAR CAGR
8.24%
5 YEAR CAGR
-11.49%
10 YEAR CAGR